24 December 2023: Articles
IgA Vasculitis in an Adult Linked to and Co-Infection: A Comprehensive Case Study
Unknown etiology
Janelle Castellino1ABCDEF*, Matas Orentas2ABEF, Dina Hassan3BD, Sonali Khandelwal2AEFDOI: 10.12659/AJCR.942394
Am J Case Rep 2023; 24:e942394
Abstract
BACKGROUND: Immunoglobulin A (IgA) vasculitis is a small-vessel vasculitis characterized by the deposition of IgA immune complexes primarily in the skin, kidneys, and gastrointestinal tract. While it predominantly affects children, cases in adults are associated with more severe manifestations. Evidence suggests that infectious triggers play a pivotal role in its etiology. Often, it follows a self-limiting course and doesn’t necessitate intervention.
CASE REPORT: We present the case of a 51-year-old man who presented with a maculopapular rash, arthralgia, and abdominal pain. An examination revealed a purpuric rash on lower extremities and abdomen. A lower extremity duplex ultrasound identified deep vein thrombosis (DVT) in the right leg. Skin biopsy of the rash confirmed the diagnosis of IgA vasculitis, demonstrating perivascular neutrophilic infiltrate and IgA complex deposition. Stool studies revealed co-infection with Cryptosporidium and Giardia. The patient was treated with a prednisone taper with significant improvement in symptoms.
CONCLUSIONS: This case highlights the potential role of Cryptosporidium as a trigger for IgA vasculitis. The presence of concurrent infections underscores the complex interplay between infections and the development of IgA vasculitis. The co-infection with Giardia suggests that a secondary infection may be involved, further complicating the disease’s etiology. The observation of DVT suggests a possible link between IgA vasculitis and a prothrombotic state. This report serves to expand the knowledge of IgA vasculitis triggers and associated complications, guiding clinicians in diagnosing and managing similar cases while emphasizing the importance of vigilance in adults with these symptoms.
Keywords: Autoimmune Diseases, Cryptosporidium, IgA Vasculitis, Vasculitis, Male, adult, Child, Humans, Middle Aged, coinfection, Giardia, Cryptosporidiosis, Immunoglobulin A, Exanthema
Background
Immunoglobulin A (IgA) vasculitis, previously known as Henoch-Schönlein Purpura, is a small-vessel vasculitis characterized by the deposition of IgA complexes primarily in the skin, kidneys, and gastrointestinal (GI) tract. Patients commonly present with palpable purpura, arthritis/arthralgia, abdominal pain, and kidney disease [1–3]. Children are more commonly affected than adults [2]. When occurring in adults, disease frequency increases in the fifth and sixth decades of life, and there appears to be is a male predominance of approximately 1.5: 1 that is not noted to occur in children [1,4]. Developing IgA vasculitis as an adult is associated with more severe disease manifestations and poorer outcomes [5]. Additionally, there is a notable seasonal fluctuation in the incidence, with a higher prevalence during the winter and fall months. It’s worth noting that this seasonal variation is more pronounced in children than in adults [4,6,7]. While the etiology and pathophysiological mechanisms remain incompletely understood, evidence suggests that abnormal immune responses triggered by environmental factors, particularly infections, may play a crucial role [7]. In the present report, we present a compelling case implicating
Case Report
A 51-year-old man with no past medical history presented to the emergency room with a 1-day history of diffuse maculopapular rash, arthralgia, and epigastric abdominal pain. The patient was a truck driver and former tobacco user (2 packs of cigarettes/day). He denied new medications or international travel prior to the development of symptoms. A physical exam noted a rash on the bilateral upper and lower extremities, and the patient reported lower extremity pain. Bilateral lower extremity duplex ultrasounds revealed deep vein thrombosis (DVT) in the right lower extremity, which was treated with a heparin drip and then transitioned to apixaban twice daily. To address the rash, the patient received a single dose of methylprednisolone 125 mg intravenously (IV). Following treatment, the patient reported improvement in symptoms and was discharged.
The patient returned to the emergency room 6 days later, reporting worsening of the rash, joint pains (now with intermittent swelling of his elbows, knees, and wrists), and worsening epigastric pain. The patient reported that the rash now covered his torso and had spread to his back. It was nonpruritic. He reported epigastric pain, which was aggravated with eating, the onset of which coincided with the onset of the rash. He also noted mild’ diarrhea, with two episodes of dark stools since the onset of symptoms. He denied hematuria.
In the emergency department, the patient was hypertensive at 150/94 mmHg, tachycardic at 113 beats per minute, and afebrile. Physical examination was notable for numerous scattered, non-blanching purpuric papules and macules ranging from bright pink to violaceous in color on the abdomen, flanks, lower back, and bilateral upper and lower extremities (Figure 1). Scaly, erythematous plaques with scattered excoriations with blood crusting encircling the right lower leg were also noted. Labs on admission were significant for leukocytosis (white blood cell count 14.04×103 cells/µL), hyponatremia (sodium 134 mmol/L), elevated C-reactive protein at 129.4 mg/L, mildly elevated blood urea nitrogen at 26 mg/dL (lab reference range, 8–21 mg/dL), serum creatinine at 0.74 mg/dL, and estimated glomerular filtration rate (GFR) >90 as reported by our lab. Urinalysis noted proteinuria, 50 mg/dL, and 12 red blood cells per high power field in the sample. In addition, the patient underwent computed tomography (CT) of the abdomen/pelvis with IV contrast, which was notable for mucosal wall thickening and fatty deposition within the distal ileum. The patient was admitted for further workup, with rheumatology and dermatology consulted due to concern about vasculitis.
Dermatology performed a punch biopsy of the rash and pathology demonstrated perivascular neutrophilic infiltrate and damage to vessel walls with hemorrhage and mild leukocytoclasia consistent with IgA vasculitis (Figure 2). Direct immunofluorescence showed predominant IgA deposition, as well as C3, and fibrin in the papillary vessel walls. Rheumatology evaluated the patient, and he was started on methylpredniso-lone 48 mg IV. Screening tests for antinuclear antibodies (ANA), complement levels, antineutrophil cytoplasmic antibody (ANCA) titers, and cryoglobulin were all negative. The urine protein-tocreatinine ratio was within normal limits. Serum IgA and other immunoglobulins were not measured. The patient’s normal creatinine and GFR levels, coupled with minimal proteinuria and hematuria, provided reassurance that renal involvement was mild. Given these findings and the confirmed diagnosis of IgA vasculitis through a skin biopsy, the decision was made to forego a renal biopsy.
The patient reported subjective improvement in rash and joint pains with the administration of methylprednisolone; however, abdominal upset persisted, and the patient had an episode of bright red blood per rectum. The patient was started on a proton pump inhibitor, and gastroenterology was consulted. The patient underwent esophagogastroduodenoscopy (EGD) and colonoscopy, which demonstrated significant necrosis in the terminal ileum with a clear transition of friable inflamed mucosa and unremarkable colonic mucosa. There were also multiple non-bleeding ulcers in the duodenum. These findings are consistent with small-vessel vasculitis involving the GI tract. The patient underwent workup for infectious GI etiologies, including stool culture,
The patient continued to improve and was discharged on a prednisone taper to be completed over 6 weeks starting at 60 mg daily. He was recommended to follow up with GI, dermatology, rheumatology, and nephrology. At subsequent rheumatology appointment one month after discharge, he denied any return of symptoms and creatinine and GFR remained within normal range.
Discussion
IgA vasculitis is characterized by a constellation of symptoms commonly involving the skin, kidneys, and GI tract. These symptoms are secondary to IgA immune complex deposition within the small vessels of these organs [2]. Biopsies of affected tissues, often skin as it is easiest to obtain, will histologically show leukocytoclastic vasculitis in postcapillary venules with IgA deposition. Palpable purpura, most notably on the lower extremities, and arthralgia/arthritis are the most common presenting symptoms in adults [1]. Renal involvement includes a spectrum ranging from mild renal abnormalities including microscopic hematuria to more severe manifestations, including nephritis and renal failure. GI symptoms such as abdominal pain, nausea, and vomiting are also common [1,2].
Our patient presented with findings consistent with classic IgA vasculitis, including a diffuse purpuric rash on bilateral lower extremities accompanied by abdominal pain, diarrhea, and migratory polyarthralgia that began a few hours after the rash developed. His renal function was normal with urinalysis being positive for microscopic hematuria. In addition, the autoimmune panel, including ANA, complement levels, ANCA titers, and cryoglobulin, were all negative, which is also consistent with IgA vasculitis. The diagnosis was then confirmed with skin and GI biopsies demonstrating the leukoclastic vasculitis pattern in small vessels with IgA complex deposition.
It is essential to acknowledge the well-established role of infectious triggering events in the development of IgA vasculitis, as substantiated by multiple studies. For instance, in a study involving 219 children with IgA vasculitis, an infectious trigger was identified in approximately 37% of cases [7,8]. Evidence of seasonal fluctuations in the incidence of IgA vasculitis further underscores the association between infections and this condition. Both adult and pediatric cases exhibit a notable increase during the winter and fall months, with a subsequent decline during the summer months. Although there is a larger body of data supporting infectious triggers in children, evidence suggests that adults are not immune to such triggers. A Korean study involving 160 patients with IgA vasculitis, including 48 adults and 112 children, noted an increased incidence of the condition during the spring and winter months in both age groups [7–9]. The distinct seasonality of this phenomenon, especially among children, may be linked to the increased prevalence of respiratory infections during the winter, as suggested by a French cohort study examining the impact of the COVID-19 pandemic on IgA vasculitis epidemiological data. It is worth noting that while there was less seasonal variation in adults, the excess risk during the winter period was elevated in both adults and children [4].
In addition, numerous case reports have identified various preceding infections as potential triggers for IgA vasculitis [7,9–11]. These infectious agents encompass a wide array of microbes, including group A
Our patient reported no prior upper respiratory symptoms or recent sick contacts. In addition, a respiratory panel including influenza, coronavirus, mycoplasma, respiratory syncytial virus, adenovirus, rhinovirus, parainfluenza, and chlamydia was negative. This makes the possibility of a respiratory source as the triggering event unlikely. Other common triggers of IgA vasculitis in adults include medications, vaccinations, and malignancy. Our patient denied recent vaccine administration, reported no new medication use, and had no overt signs of malignancy. Given this, the patient underwent further infectious testing as well as colonoscopy and EGD. Stool studies revealed a positive result for
Generally, immunocompetent individuals do not require specific therapy, and supportive care is usually all that is necessary [17].
Protozoal infections, including
In addition to our patient’s presentation of
Finally, most cases of IgA vasculitis are self-limited and resolve without intervention [23]. Treatment is typically supportive and includes acetaminophen or non-steroidal anti-inflammatory medications such as naproxen for arthralgias. It was previously thought that a course of corticosteroids could be used to prevent renal complications; however, a 2015 Cochrane review concluded that there was not enough evidence to support that theory [24]. The decision to treat our patient with a corticosteroid taper was based on the severity of his polyarthralgia, persistent abdominal pain, and diffuse rash. He noted rapid improvement in rash and arthralgias while abdominal pain was slower to respond.
Conclusions
This case report provides insight into a typical presentation of IgA vasculitis in an adult with concurrent
Figures
Figure 1.. Skin findings on patient presentation in the hospital. (A) Abdomen with many scattered, non-blanching purpuric papules and macules ranging from bright pink to violaceous in color. (B) The patient’s ankles with non-blanching purpuric papules and macules. (C) Medial aspect of lower extremity with purpuric rash Figure 2.. (A–D) Skin biopsy of purpuric lesions which demonstrate IgA vasculitis, showing a typical finding in skin, with leukocytoclastic vasculitis. Prominent inflammatory infiltrate including neutrophils was present in the dermal capillaries, and marked, extravasated red blood cells were seen in the dermis.References:
1.. Villatoro-Villar M, Crowson CS, Warrington KJ, Clinical characteristics of biopsy-proven IgA vasculitis in children and adults: A retrospective cohort study: Mayo Clin Proc, 2019; 94(9); 1769-80
2.. Mills JA, Michel BA, Bloch DA, The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura: Arthritis Rheum, 1990; 33(8); 1114-21
3.. Piram M, Mahr A, Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge: Curr Opin Rheumatol, 2013; 25(2); 171-78
4.. Maisons V, Ramdani Y, Hankard A, New insights into epidemiological data and impact of the COVID-19 pandemic on IgA vasculitis in children and adults: A French nationwide cohort: Rheumatol Int, 2023; 34(10); 1791-98
5.. Kang Y, Park JS, Ha YJ, Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura: J Korean Med Sci, 2014; 29(2); 198-203
6.. Hwang HH, Lim IS, Choi BS, Yi DY, Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases: Medicine (Baltimore), 2018; 97(36); e12217
7.. Rigante D, Castellazzi L, Bosco A, Esposito S, Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura?: Autoimmun Rev, 2013; 2(10); 1016-21
8.. Coppo R, Amore A, Gianoglio B, Clinical features of Henoch-Schönlein purpura. Italian Group of Renal Immunopathology: Ann Med Interne (Paris), 1999; 150(2); 143-50
9.. Tang C, Scaramangas-Plumley D, Nast CC, A case of Henoch-Schonlein purpura associated with rotavirus infection in an elderly Asian male and review of the literature: Am J Case Rep, 2017; 18; 136-42
10.. Pillebout E, Sunderkötter C, IgA vasculitis: Semin Immunopathol, 2021; 43(5); 729-38
11.. Nikolaishvili M, Pazhava A, Di Lernia V, Viral infections may be associated with Henoch-Schönlein purpura: J Clin Med, 2023; 12(2); 697
12.. Current W, Garcia LS, Cryptosporidiosis: Clin Microbiol Rev, 1991; 4; 325-58
13.. Zhu G, Keithly JS, Philippe H: Int J Syst Evol Microbiol, 2000; 50; 1673-1681
14.. Widmer G, Carmena D, Kváč M: Parasite, 2020; 27; 14
15.. Ryan U, Hijjawi N, Xiao L, Foodborne cryptosporidiosis: Int J Parasitol, 2018; 48; 1-12
16.. Bouzid M, Hunter PR, Chalmers RM, Tyler KM: Clin Microbiol Rev, 2013; 26(1); 115-34
17.. Chen XM, Keithly JS, Paya CV, LaRusso NF, Cryptosporidiosis: N Engl J Med, 2002; 346; 1723-31
18.. Du L, Wang P, Liu C, Multisystemic manifestations of IgA vasculitis: Clin Rheumatol, 2021; 40; 43-52
19.. Zaidi AU, Berman B, Crossing the thrombotic threshold: Deep vein thrombosis in Henoch-Schönlein purpura: Clin Pediatrics, 2014; 53(14); 1396-98
20.. Soriano A, Galati G, Vespasiani-Gentilucci U, A case of Henoch-Schönlein purpura in the elderly: Not just a ‘second childhood’: Aging Clin Exp Res, 2012; 24(5); 559-60
21.. Sari I, Akar S, Secil M, Thrombosis and priapism in a patient with Henoch-Schonlein purpura: Rheumatol Int, 2005; 25; 472-74
22.. Monastiri K, Selmi H, Tabarki B, Primary antiphospholipid syndrome presenting as complicated Henoch-Schönlein purpura: Arch Dis Childhood, 2002; 86; 132-33
23.. Reamy BV, Servey JT, Williams PM, Henoch-Schönlein purpura (IgA vasculitis): Rapid evidence review: Am Fam Physician, 2020; 102(4); 229-33
24.. Hahn D, Hodson EM, Willis NS, Craig JC, Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP): Cochrane Database Syst Rev, 2015; 2015(8); CD005128
Figures
In Press
Case report
Pathological Complete Response with Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy Followed by Modif...Am J Case Rep In Press; DOI: 10.12659/AJCR.943936
Case report
Uncommon Presentation of Hypersplenism in Adult Sickle Cell Disease Patients: A Rare Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.944693
Case report
A Rare Case of Idiopathic Reversible Cerebral Vasoconstriction SyndromeAm J Case Rep In Press; DOI: 10.12659/AJCR.944273
Case report
Coexisting Sacroiliac Arthritis and Chronic Nonbacterial Osteomyelitis in an Adolescent with Ehlers-Danlos ...Am J Case Rep In Press; DOI: 10.12659/AJCR.943579
Most Viewed Current Articles
07 Mar 2024 : Case report 41,772
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report 32,260
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
21 Jun 2024 : Case report 47,701
Intracranial Parasitic Fetus in a Living Infant: A Case Study with Surgical Intervention and Prognosis Anal...DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
23 Feb 2022 : Case report 19,468
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250